Close

Piper Sandler Starts Gracell Biotechnologies Inc (GRCL) at Overweight

February 2, 2021 4:28 AM EST Send to a Friend
Piper Sandler analyst Tyler Van Buren initiates coverage on Gracell Biotechnologies Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login